UK biotech races US giants for longevity breakthrough
The Guardian - 05-Nov-2023British researchers and startups vie to outpace tech billionaires in the fight against ageing
UNITY Biotechnology
Biotechnology company devoted to research of restoring human health
UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.
Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial focus is on delivering localized therapy in ophthalmologic diseases, including diabetic macular edema and age-related macular degeneration, and age-related neurologic conditions.
Visit website: https://unitybiotechnology.com/
Details last updated 04-Feb-2019
People at UNITY Biotechnology
UNITY Biotechnology News
UNITY Biotech's lead compound lags behind the Regeneron’s eye drug
Biospace - 27-May-2023UBX1325 showed disappointing results in phase II macular degeneration trial - further analysis is required
Unity Biotechnology's diabetic macular edema senolytic treatment shows promise at 48-week endpoint
FierceBiotech - 24-Apr-2023Corporate shift towards ophthalmology puts senolytics head-to-head against existing treatments
Data from Phase 2 BEHOLD study of UBX1325 in DME patients-Unity Biotechnology
Ophthalmology Times - 12-Aug-2022Statistically significant treatment effect for both BCVA and CST was seen at both 12 and 18 weeks
Longevity.Technology looks at 12 key companies running age-related disease clinical trials in 2021
Longevity Technology - 25-Feb-2022Approaches include senotherapeutics, stem cells and mitochondria. Eye disease is a common first target.
Longevity Technology interviews Aubrey de Grey about senolytics and other senotherapeutics
Longevity Technology - 05-Aug-2021Most approaches have their limitations but good progress is being made on several fronts
Unity's senolytic drug reports positive phase 1 data in eye disease patients
FierceBiotech - 06-Jul-2021Begun phase 2 trial including patients with early stage of disease to test its safety and effectiveness
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021More and more companies making greater and greater progress - 2021 could be an exciting year
LMC provides background and success outlook on 14 leading senolytic companies
Longevity Marketcap - 15-Dec-2020Comprehensive review of companies' clinical and financial state of play
Unity Biotechnology launches clinical trial of a new senolytic
Lifespan.io (LEAF) - 13-Oct-2020A new approach to treat diabetic macular oedema
Labiotech gathers feedback from European biotechs on Unity failure
Labiotech - 28-Aug-2020General feeling that failures are bound to happen - but that their approaches can succeed
Reason examines the failure of Unity Biotechnology's phase 2 senolytics trial
Fight Aging! - 18-Aug-2020Disappointing first result - but lessons learnt and plenty of other strategies available
Research into klotho is at a very interesting point
Fight Aging! - 03-Jun-2019Research community is littered with interesting, promising foundations for therapies to treat aging
UNITY Biotechnology expands trial of osteoarthritis senolytic
UNITY Biotechnology - 22-Jan-2019Initial results must be promising to enrol more patients at highest dosage
UNITY Biotechnologies Selects a New Senolytic Candidate
Lifespan.io (LEAF) - 14-Jan-2019Very early days but good to have more senolytics in the pipeline
The path to an extended health span and a healthier death
MIT Technology Review - 23-Oct-2018Still a long way to go before expanding life span
Cleara Biotech Joins the Race to Develop Senolytic Therapies
Lifespan.io (LEAF) - 09-Jul-2018This therapy uses a modified FOXO4 to promote apoptosis in senescent cells
Silicon Valley and rich people invest to slow down ageing and live longer
This Is Money - 17-Mar-2018All the money in the world to fight ageing and death
SRF has made progress in the fight against ageing
Lifespan.io (LEAF) - 05-Dec-2017R&D phase in SENS repair approach has shown promising results
Here are the ways Silicon Valley plans to conquer death
National Post - 03-Nov-2017Billionaires are now pouring millions into longevity research. Upgrading the human immune system...
To stay young, kill zombie cells
Nature - 24-Oct-2017Proof-of-concept trials starting that pit senolytic drugs against a range of age-related ailments...
Treating Osteoarthritis by Removing Senescent Cells
Lifespan.io (LEAF) - 03-May-2017Researchers used local clearance of senescent cells (in mice) to reduce the development of post-t...
Hallmark of Aging Reversed by Senescent Cell Removal
Lifespan.io (LEAF) - 25-Mar-2017Study directly targets one of the mechanisms that senescent cells use to avoid apoptosis, Focuse...
Exciting Therapy To Treat Age Related Blindness Moving To The Clinic
Lifespan.io (LEAF) - 15-Feb-2017Ichor Therapeutics is a biotechnology company focused on developing drugs for age-related disease...
Fight Aging predicts the sequence of arrival for meaningful antiaging therapies
Next Big Future - 01-Dec-2016Each treatment will target a different type of molecular damage in cells and tissues. 1) Clearan...
This start-up believes it can slow the aging process
Washington Post - 28-Oct-2016Unity Biotechnology’s technology jump starts senescent cells into dividing again. Company has ra...
